Do proton pump inhibitors protect against cancer progression in GERD? - Wikidata - awgldk - TriplyDB

Do proton pump inhibitors protect against cancer progression in GERD?

Do proton pump inhibitors protect against cancer progression in GERD?

http://www.wikidata.org/entity/Q38056614

about

The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.The role of inflammation in cancer of the esophagus.Activation of NADPH oxidases leads to DNA damage in esophageal cells.Oxidative stress from reflux esophagitis to esophageal cancer: the alleviation with antioxidants.Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.

P2860

Q34485137-8F6E0E37-AF59-4722-9B19-4D2A4E0B76A0 Q35441801-19A25B2F-11CB-41D6-A8FB-F56EBA6F1DC6 Q35954977-475CA453-5D5E-4F23-9FDD-406EF7EE1FCD Q36245569-DB9AAD88-58EB-4757-A5E4-C456D8B944BD Q38214324-9B0A519D-0175-4490-AE8F-6E1942CCED53 Q38601588-CA92BF95-A9E7-415E-9CC4-21BBF97DA336 Q38816252-3EBBFEE4-A3B9-4B24-8DCD-2FDB663E53EB Q55709336-66AFA396-9154-4C51-BB7F-98BB851BC190

P2860

Do proton pump inhibitors protect against cancer progression in GERD?

http://www.wikidata.org/entity/Q38056614

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Do proton pump inhibitors protect against cancer progression in GERD?

@en

type

label

Do proton pump inhibitors protect against cancer progression in GERD?

@en

prefLabel

Do proton pump inhibitors protect against cancer progression in GERD?

@en

P1433

Q38056614-A7BE0CB8-3710-4315-81F5-85A8C045E04A

P1476

Q38056614-1ECBB7CF-E27B-4BA1-BF60-BE57799E1AD6

P2093

Q38056614-05B380D0-E8A3-4AAD-9801-B3D2FB8A9743

Q38056614-1ACB680C-D693-4ABC-8DB2-1CFE4CCE5DB0

Q38056614-2990AD9C-9015-4D42-B246-F34003EC8E62

Q38056614-30053BCF-BAE5-446F-AC53-47610BC0A9F0

Q38056614-4B3A80E6-15E2-4E43-8492-0C8B3A8D478B

Q38056614-5D2FC0D0-3A1E-443B-AFC8-023D8C4CD9CB

Q38056614-5E5F3048-3EF6-4FEF-BE7C-3FDB840ED032

Q38056614-5FF25E2E-79C8-4122-B67D-0AB71A0452A2

Q38056614-74D2D20D-A733-4CF2-9C8A-EFF060C3E7CA

Q38056614-8C13C6BD-8B90-4F75-B9ED-D46E0F824465

P2860

Q38056614-03D46FDA-D068-463C-807E-727917A9E14F

Q38056614-0713A9A0-8770-4BC6-AB55-ADCF75426C00

Q38056614-1CB3A4FA-4D6A-4DDF-BE5F-8808A5975E94

Q38056614-257739AD-AD01-4B0E-9F2D-F30D5791A35D

Q38056614-259F01C4-531A-4955-B895-00EBB794187A

Q38056614-2E0009FB-31E6-49F0-904D-6CD44B2F7402

Q38056614-3008147B-6585-4F0C-B9D1-D8D36D42D331

Q38056614-35C4C962-FD18-4827-A925-7AC58A7B124C

Q38056614-3DC0FB17-DC2E-44C0-833F-FBE116B2CC90

Q38056614-3E4C4B62-C1B6-47C3-8A63-9CCE45F9F0F8

P304

Q38056614-95AEA465-1494-4551-B706-8FD83FC0F473

P31

Q38056614-8C55DCEC-4AE3-4E6D-A0F9-FBEDEF4F7ABA

P356

Q38056614-2C78A632-886E-4BCB-AD3E-370579908EDC

P433

Q38056614-10AA1B5F-C2B6-4BB7-B3DF-693366955B7D

P478

Q38056614-CEC7F584-76FD-4DAD-BEAF-8B937A13E491

P50

Q38056614-FCADA350-731D-4D57-B4B1-7E9099D3B9D3

P577

Q38056614-7323AEC8-2FB6-4D20-92CD-264839A13365

P698

Q38056614-4DFF3C6D-B312-4A25-9E68-157480B9580A

P356

S00595-012-0395-2

P1433

P1476

Do proton pump inhibitors protect against cancer progression in GERD?

@en

P2093

Daisuke Matsui

http://www.w3.org/2001/XMLSchema#string

Furhawn A Shah

http://www.w3.org/2001/XMLSchema#string

Hidehiro Tajima

http://www.w3.org/2001/XMLSchema#string

Hideto Fujita

http://www.w3.org/2001/XMLSchema#string

Hirohisa Kitagawa

http://www.w3.org/2001/XMLSchema#string

Hironori Hayashi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Takamura

http://www.w3.org/2001/XMLSchema#string

Hisatoshi Nakagawara

http://www.w3.org/2001/XMLSchema#string

Isamu Makino

http://www.w3.org/2001/XMLSchema#string

Itasu Ninomiya

http://www.w3.org/2001/XMLSchema#string

P2860

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature

Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective

Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience

Double balloon enteroscopy in children: diagnosis, treatment, and safety

Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia.

Barrett's esophagus and animal models.

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Cancer statistics, 1998.

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

P304

831-837

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00595-012-0395-2

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23111465

http://www.w3.org/2001/XMLSchema#string